Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.35 $11,038 - $15,533
6,610 Added 35.51%
25,227 $46,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $717,203 - $1.09 Million
-396,245 Reduced 95.51%
18,617 $36,000
Q2 2022

Aug 08, 2022

BUY
$1.34 - $5.34 $555,915 - $2.22 Million
414,862 New
414,862 $863,000
Q2 2019

Aug 14, 2019

SELL
$2.05 - $4.32 $88,010 - $185,466
-42,932 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$1.79 - $3.12 $76,848 - $133,947
42,932 New
42,932 $90,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.